Coverage for obesity drugs, including GLP1 medications, rose to 44% of large employers (500+ employees) in 2024, and 64% of the largest employers (20,000+ employees) now offer this coverage, according to data from Mercer
Semaglutide works more like a volume control that turns down hunger signals rather than completely shutting them off
Although ocular toxicity is generally not life-threatening, it can still substantially affect patients daily activities and adherence to treatment
Research shows GLP-1 signaling influences dopamine pathways in areas responsible for reward, motivation, and impulse control
In practical terms, this is unlikely to significantly impact the effectiveness of Pepto-Bismol for symptom relief, but it is a factor worth considering
GHK-Cu and SNAP-8 are included for their roles in peptide-based skincare, while Hyaluronic Acid provides multi-layer hydration